Rekah Pharmaceutical Industry Ltd (REKA):企業の財務・戦略的SWOT分析

◆英語タイトル:Rekah Pharmaceutical Industry Ltd (REKA) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2900
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Rekah Pharmaceutical Industry Ltd (REKA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Rekah Pharmaceutical Industry Ltd (Rekah) undertakes the manufacturing, marketing, sale and distribution of pharmaceuticals, OTC drugs, cosmetics, nutritional supplements and vitamins. It manufactures and markets products in sterile production, liquid, pill, cream and powder forms. The company offers products for the treatment of medical conditions such as allergic infections and dryness of the eyes, steroid anti-inflammatories, anxiety and depression, fungal infections, urinary tract pain, anemia, heart burn, anemia, diarrhea, winter illness and nutritional deficits, among others. Rekah works in collaboration with hospitals, government institutions, supermarket retail chains, private pharmacies, natural products stores, pharmacy chains, cosmetics stores and others to distribute and sell its products. Rekah is headquartered in Holon, Israel.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Rekah Pharmaceutical Industry Ltd – Key Facts 5
Rekah Pharmaceutical Industry Ltd – Key Employees 6
Rekah Pharmaceutical Industry Ltd – Major Products and Services 7
Rekah Pharmaceutical Industry Ltd – History 8
Rekah Pharmaceutical Industry Ltd – Company Statement 9
Rekah Pharmaceutical Industry Ltd – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Company Overview 11
Rekah Pharmaceutical Industry Ltd – Business Description 12
Rekah Pharmaceutical Industry Ltd – SWOT Analysis 13
SWOT Analysis – Overview 13
Rekah Pharmaceutical Industry Ltd – Strengths 13
Rekah Pharmaceutical Industry Ltd – Weaknesses 14
Rekah Pharmaceutical Industry Ltd – Opportunities 15
Rekah Pharmaceutical Industry Ltd – Threats 16
Rekah Pharmaceutical Industry Ltd – Key Competitors 17
Section 3 – Company Financial Ratios 18
Financial Ratios – Capital Market Ratios 18
Financial Ratios – Annual Ratios 19
Performance Chart 22
Financial Performance 22
Financial Ratios – Interim Ratios 23
Financial Ratios – Ratio Charts 24
Section 4 – Appendix 25
Methodology 25
Ratio Definitions 25
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Rekah Pharmaceutical Industry Ltd, Key Facts 5
Rekah Pharmaceutical Industry Ltd, Key Employees 6
Rekah Pharmaceutical Industry Ltd, Major Products and Services 7
Rekah Pharmaceutical Industry Ltd, History 8
Rekah Pharmaceutical Industry Ltd, Subsidiaries 10
Rekah Pharmaceutical Industry Ltd, Key Competitors 17
Rekah Pharmaceutical Industry Ltd, Ratios based on current share price 18
Rekah Pharmaceutical Industry Ltd, Annual Ratios 19
Rekah Pharmaceutical Industry Ltd, Annual Ratios (Cont...1) 20
Rekah Pharmaceutical Industry Ltd, Annual Ratios (Cont...2) 21
Rekah Pharmaceutical Industry Ltd, Interim Ratios 23
Currency Codes 25
Capital Market Ratios 25
Equity Ratios 26
Profitability Ratios 26
Cost Ratios 27
Liquidity Ratios 27
Leverage Ratios 28
Efficiency Ratios 28

List of Figures
Rekah Pharmaceutical Industry Ltd, Performance Chart (2013 - 2017) 22
Rekah Pharmaceutical Industry Ltd, Ratio Charts 24

★海外企業調査レポート[Rekah Pharmaceutical Industry Ltd (REKA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ADx NeuroSciences NV:企業の製品パイプライン分析2018
    Summary ADx NeuroSciences NV (ADx NeuroSciences) is a medical device company that develops proprietary biomarkers for various neurodegenerative diseases. The company offers biomarkers for Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. It also develops and commercializes analyti …
  • NCR Corporation:戦略・SWOT・企業財務分析
    NCR Corporation - Strategy, SWOT and Corporate Finance Report Summary NCR Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • JCDecaux SA:企業の戦略・SWOT・財務情報
    JCDecaux SA - Strategy, SWOT and Corporate Finance Report Summary JCDecaux SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Telekom Austria AG:企業の戦略・SWOT・財務情報
    Telekom Austria AG - Strategy, SWOT and Corporate Finance Report Summary Telekom Austria AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Norwegian Air Shuttle ASA:企業の戦略・SWOT・財務情報
    Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report Summary Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • OncoSil Medical Ltd (OSL):企業の財務・戦略的SWOT分析
    Summary OncoSil Medical Ltd (OncoSil), is a medical device company that develops and commercializes products for the treatment of pancreatic and liver cancer. The company’s lead product includes oncosil, a brachytherapy device that emits beta radiation and is implanted directly inside the cancerous …
  • Chicago Bridge & Iron Company N.V.:企業の戦略・SWOT・財務情報
    Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report Summary Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Celestica Inc.:企業の戦略・SWOT・財務情報
    Celestica Inc. - Strategy, SWOT and Corporate Finance Report Summary Celestica Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • National Bank of Canada:企業の戦略・SWOT・財務分析
    National Bank of Canada - Strategy, SWOT and Corporate Finance Report Summary National Bank of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Strat Aero Plc (AERO):企業の財務・戦略的SWOT分析
    Summary Strat Aero Plc (Strat Aero) formally known as Remote Monitored Systems PLC is an aerospace company that offers management systems, training solutions and consultancy services to the Unmanned Aerial Vehicle (UAV) sector. The company’s services include survey and inspection services, surveilla …
  • Louisiana-Pacific Corp (LPX):企業の財務・戦略的SWOT分析
    Louisiana-Pacific Corp (LPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Edmond de Rothschild (Suisse) S.A.:企業の戦略・SWOT・財務情報
    Edmond de Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report Summary Edmond de Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析
    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cabot Microelectronics Corp (CCMP):企業の財務・戦略的SWOT分析
    Cabot Microelectronics Corp (CCMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Innate Pharma SA (IPH):企業の財務・戦略的SWOT分析
    Summary Innate Pharma SA (Innate Pharma) is a biotechnology company developing antibodies to treat cancer by harnessing the immune system. It offers Lumoxiti, a CD22-directed immunotoxin for the treatment of relapsed or refractory hairy cell leukemia (HCL). The company is investigating drugs against …
  • Eskom Uganda Ltd:企業の戦略的SWOT分析
    Eskom Uganda Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):企業の財務・戦略的SWOT分析
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • Ramsay Health Care Ltd (RHC):企業の財務・戦略的SWOT分析
    Ramsay Health Care Ltd (RHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Swiss Life Holding Ltd:企業のM&A・事業提携・投資動向
    Swiss Life Holding Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swiss Life Holding Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Audentes Therapeutics Inc (BOLD)-製薬・医療分野:企業M&A・提携分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myop …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆